These advancements focus on prodrugs and derivatives to overcome challenges limiting psychedelics' medical use. New patents ...

This shift in focus brings attention to prodrugs – medications that start as inactive or less active, and once inside the ...

Prodrugs are medications that start as inactive or less active, and once inside the body, are converted into the active form, ...

Janney Montgomery Scott LLC decreased its position in shares of Zevra Therapeutics, Inc. (NASDAQ:ZVRA – Free Report) by 29.5% ...

Researchers from IOCB Prague have succeeded in preparing compounds capable of activating prodrugs at predetermined locations in the body, enhancing their effectiveness and expediting their action.

Zevra Therapeutics (ZVRA) Company Description: KemPharm, Inc. is a clinical-stage specialty pharmaceutical company, which engages in the discovery and development of proprietary prodrugs. It focuses ...

Experiments in which they tested the effectiveness of activating the prodrugs in cell culture on colon and prostrate cancer cells showed the antibody to be effective at therapeutically relevant ...

MAIA will present the results of preclinical studies for its new THIO-based prodrugs, designated as MAIA-2021-20 and MAIA-2022-12, which are lipid-conjugated compounds derived from THIO.

Medivir is developing tumor-directed nucleotide oral prodrugs to treat cancers with highly unmet medical needs. The company’s lead drug candidate, MIV-818, is a liver cancer targeted prodrug ...

The Danish pharma group is pledging $285 million in upfront and milestone payments for the lead GLP-1 asset in the ...

Aqsa Arif, a Pakistani PhD student from the LEJ Nanotechnology Centre at the HEJ Research Institute of Chemistry, University ...

PureTech-founded Seaport Therapeutics has raised $225m in a Series B financing round to support the development of new prodrug treatments for psychiatric disorders. Seaport plans to use the new ...